Posted in | News | Medical Robotics

RP-VITA Telemedicine Robot to be Showcased at 2012 Clinical Innovations Forum

InTouch Health and iRobot declared that during the InTouch Health 7th Annual Clinical Innovations Forum, the companies will showcase the innovative RP-VITA (Remote Presence Virtual + Independent Telemedicine Assistant). The event will take place from July 26 to 28 in Santa Barbara, California.

InTouch Health and iRobot to Unveil the RP-VITATM Telemedicine Robot at Clinical Innovations Forum

Being the first remote patient care solution, the RP-VITA integrates InTouch Health's novel telemedicine technology with the modern autonomous navigation and mobility created for the iRobot Ava mobile robotics platform.

The RP-VITA has been developed following a joint development and licensing agreement between two major companies. In addition to being a broad telemedicine technology platform, the RP-VITA is the total acute care telemedicine solution's remote presence device component. InTouch Health will commercialize the RP-VITA as its new flagship remote presence device. iRobot will further look for nearby market opportunities for RP-VITA and iRobot Ava robots.

The RP-VITA enables health professionals to remotely control the clinical, patient or care team management process that leads to right and quick decision and medical action. It provides extensive clinical information and ensures the healthcare team with a new level of utility, mobility, and simple application in the acute care market.

The new innovative RP-VITA provides real-time access to major clinical data, creating new workflow improvements for the medical team. RP-VITA can be in-built within diagnostic devices such as electronic stethoscope, otoscopes and ultrasound and can also be linked to live patient data from the electronic medical record. It features an improved navigation capability through which the RP-VITA can have enhanced management in driving and navigation elements. In addition, navigation can be improved by using mapping and Obstacle Detection Obstacle Avoidance (ODOA) technologies. Also, a new, user-friendly iPad1 user interface promotes flexible navigation for RP-VITA and ensures efficient interaction with the patient, care team and the patient's family. Furthermore, the RP-VITA's additional capability integrates autonomous navigation which has been submitted to the FDA for 510(k) clearance due in Q4 2012.

InTouch Health foresees that this versatile RP-VITA platform will create additional value in leveraging team-wide care, providing maximum care experience.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kaur, Kalwinder. (2019, February 20). RP-VITA Telemedicine Robot to be Showcased at 2012 Clinical Innovations Forum. AZoRobotics. Retrieved on November 25, 2024 from https://www.azorobotics.com/News.aspx?newsID=3037.

  • MLA

    Kaur, Kalwinder. "RP-VITA Telemedicine Robot to be Showcased at 2012 Clinical Innovations Forum". AZoRobotics. 25 November 2024. <https://www.azorobotics.com/News.aspx?newsID=3037>.

  • Chicago

    Kaur, Kalwinder. "RP-VITA Telemedicine Robot to be Showcased at 2012 Clinical Innovations Forum". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=3037. (accessed November 25, 2024).

  • Harvard

    Kaur, Kalwinder. 2019. RP-VITA Telemedicine Robot to be Showcased at 2012 Clinical Innovations Forum. AZoRobotics, viewed 25 November 2024, https://www.azorobotics.com/News.aspx?newsID=3037.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.